Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the... GlobeNewswire
Market data is delayed by at least 15 minutes.
    Latest Story Top Stories on VYGR
    No News Available
    Voyager Therapeutics Reports First Quarter 2024 Financial and Operati...
    4:01p ET May 13 '24 GlobeNewswire
    Voyager Therapeutics Presents Data for Second-Generation, TRACER(TM)-...
    6:00a ET May 8 '24 GlobeNewswire
    Voyager Therapeutics Announces First Quarter 2024 Conference Call and...
    7:00a ET May 6 '24 GlobeNewswire
    Voyager Therapeutics to Present Broad Set of Translational Data Suppo...
    4:30p ET April 22 '24 GlobeNewswire
    Voyager Therapeutics Announces Selection of Development Candidate for...
    7:00a ET April 16 '24 GlobeNewswire
    Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing...
    4:01p ET March 26 '24 GlobeNewswire
    Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief ...
    7:00a ET March 13 '24 GlobeNewswire
    Voyager Therapeutics Reports Fourth Quarter and Full Year 2023 Financ...
    4:01p ET February 28 '24 GlobeNewswire
    Voyager Therapeutics Announces Selection of Gene Therapy Development ...
    7:00a ET February 26 '24 GlobeNewswire
    Voyager Therapeutics Announces Fourth Quarter 2023 Conference Call an...
    7:00a ET February 21 '24 GlobeNewswire

    Market data provided by News provided by